08 April 2021
The antiviral drug favipiravir will be investigated as a treatment for COVID-19 in people recovering at home and in other non-hospital settings, in a clinical trial funded and supported by the NIHR.
06 April 2021
An NIHR supported study into the effects of a vegan diet in people with or at risk of developing type 2 diabetes has found that a plant-based lifestyle may help control blood glucose levels.
25 March 2021
The NIHR has launched a second call for research proposals on helping and supporting people with Long COVID.
25 March 2021
A new NIHR funded study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
24 March 2021
The NIHR has announced the fourth phase of the School for Primary Care Research (SPCR), with a refreshed membership and a new focus on supporting the full spectrum of primary care research and building research capacity.
23 March 2021
NIHR and partner organisations across the health research ecosystem have today welcomed the publication of a bold and ambitious vision for the future of clinical research delivery in the UK.
15 March 2021
A new NIHR-funded study will investigate whether Cognitive Behavioural Therapy (CBT) could help reduce the worryingly high number of children who are afraid of the dentist.
12 March 2021
The National Institute for Health Research (NIHR) has published its latest annual report highlighting its milestones and achievements during 2019/20.
08 March 2021
An NIHR national specialty lead, Professor Peter Goadsby, is one of a group of four neuroscientists to receive this year’s The Brain Prize - one of the world’s most prestigious awards in neuroscience.
04 March 2021
The NIHR has partnered with NHS Blood and Transplant (NHS BT) to announce a funding competition to award £19.9 million to new NIHR Blood and Transplant Research Units (BTRUs).
03 March 2021
A NIHR-supported study evaluating potential COVID-19 treatments that can be taken at home will now expand for the first time to include adults of any age
03 March 2021
The NIHR has announced the appointment of 46 NIHR Senior Investigators in the 2021 round of awards.
23 February 2021
NIHR-funded review highlights key challenges around the prevention and management of chronic respiratory diseases in low-and middle-income countries (LMICs) and how they can provide quality care to people, which is equitable and affordable.
22 February 2021
Vaccination has been linked to a substantial reduction in the risk of Covid-19 admissions to Scotland’s hospitals, landmark research suggests.
19 February 2021
NIHR-supported researchers have shown that a new technique to grow ‘mini bile ducts’ in a lab can be used to repair damaged human donor livers. In the future this new technique could potentially help treat patients whose own livers are not functioning correctly.
18 February 2021
The NIHR and UK Research and Innovation (UKRI) have funded four new research studies to better understand and address the longer term effects of COVID-19 on physical and mental health.
17 February 2021
Oncology research experts from across the country have come together to establish a new collaboration to accelerate cancer research, translating scientific discoveries into tangible benefits for patients.
15 February 2021
Oxford University extends COVID-19 vaccine study to children
11 February 2021
The NIHR-supported RECOVERY trial has shown that tocilizumab - an anti-inflammatory rheumatoid arthritis treatment - reduces the risk of death for hospitalised patients with severe COVID-19.
11 February 2021
NIHR-supported researchers have created a new data tool to enable local authorities and the NHS to deliver targeted responses into communities at higher risk to COVID-19.
08 February 2021
The NIHR Clinical Research Network (CRN) has appointed Divya Chadha Manek as its new Director of Business Development and Marketing.
08 February 2021
The NIHR has launched a new call to fund research to compare head-to-head the clinical effectiveness of the licensed COVID-19 vaccines being used in the UK.
02 February 2021
The NIHR-supported RECOVERY trial has begun investigating the anti-inflammatory arthritis drug, baricitinib, as a potential treatment for hospitalised COVID-19 patients.
29 January 2021
The NIHR-supported Novavax COVID-19 vaccine, developed by the US-based biotechnology firm, is 89.3% effective at preventing COVID-19, shown from interim analysis of its Phase III study data.
29 January 2021
NIHR supported research has found being overweight is an additional burden on brain health and it may exacerbate Alzheimer’s disease.